( in Million)
Particulars
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
6848.62
5816.8
5861.07
5437.16
Total Expenditure
6076.11
5128.07
5141.83
4758.61
PBIDT (Excl OI)
772.51
688.73
719.24
678.55
Other Income
190.65
5.09
16.04
12
Operating Profit
963.16
693.82
735.28
690.55
Interest
90.59
76.65
60.91
57.28
Exceptional Items
NA
NA
NA
NA
PBDT
872.57
617.17
674.37
633.27
Depreciation
235.28
196.14
182.33
177.49
Profit Before Tax
637.29
421.03
492.04
455.78
Tax
182.76
97.27
127.96
125.03
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
454.53
323.76
364.08
330.75
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
454.53
323.76
364.08
330.75
Minority Interest
NA
NA
NA
NA
Shares of Associates
5.14
3.98
4.68
5.21
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
459.67
327.74
368.76
335.96
Equity Capital
110.77
110.76
110.73
110.73
Calculated EPS
8.29
5.91
6.66
6.06
Calculated EPS (Annualised)
33.19
23.67
26.64
24.27
No of Public Share Holdings
17637866
17635866
17621466
17621091
% of Public Share Holdings
31.85
31.84
31.83
31.83
PBIDTM% (Excl OI)
11.27
11.84
12.27
12.47
PBIDTM%
14.06
11.92
12.54
12.70
PBDTM%
12.74
10.61
11.50
11.64